Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Non - Alcoholic Steatohepatitis”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableUnknownNCT05734599
What this trial is testing

NMR-based Metabolic Profiling Identifies High Risk of MAFLD Patients With Advanced Fibrosis

Who this might be right for
Metabolic Dysfunction-associated Fatty Liver DiseaseMetabolic Disease
Huazhong University of Science and Technology 1,194
Large-scale testing (Phase 3)Active Not RecruitingNCT06884293
What this trial is testing

A Study Comparing IBI362 vs Semaglutide in Chinese Overweight or Obese Adults With Metabolic Dysfunction-associated Fatty Liver Disease （MAFLD）

Who this might be right for
OverweightMetabolic Dysfunction-associated Fatty Liver Disease (MAFLD)
Innovent Biologics (Suzhou) Co. Ltd. 479
Large-scale testing (Phase 3)Study completedNCT02395900
What this trial is testing

The Effects of Flaxseed Supplement on Biochemical Factors and Hepatic Fibrosis in Patients With Nonalcoholic Fatty Liver Disease

Who this might be right for
Non Alcoholic Steatohepatitis
National Nutrition and Food Technology Institute 50
Not applicableStudy completedNCT06344364
What this trial is testing

Digital Pathology and AI for Liver Outcomes in MASLD

Who this might be right for
Metabolic Dysfunction-associated Steatotic Liver Disease
PharmaNest, Inc 1,241
Not applicableStudy completedNCT01985009
What this trial is testing

Prospective, Cross-sectional and Multicenter Study, Evaluating the Diagnosis Accuracy of the Controlled Attenuation Parameter(CAP) Measured by FibroScan® (Either With M+ or XL+ Probe) in Patient With Non-Alcoholic Fatty Liver Disease Using Liver Biopsy as Reference.

Who this might be right for
Non-alcoholic Fatty Liver Disease
Echosens 450
Not applicableStudy completedNCT04452409
What this trial is testing

Enhanced Liver Function in Non-alcoholic Obese Fatty Liver Patients by Low Level Laser Therapy

Who this might be right for
Fatty Liver, NonalcoholicLiver Function
Cairo University 60
Not applicableStudy completedNCT01696487
What this trial is testing

Impact of Fructose Consumption on Intestinal Permeability in Non-alcoholic Fatty Liver Disease (NAFLD) - a Pilot Study.

Who this might be right for
Non-alcoholic Fatty Liver DiseaseNon-alcoholic Steatohepatitis
Medical University of Vienna 10
Not applicableStudy completedNCT04616664
What this trial is testing

Diagnostic Accuracy of the "LLIFT", a Novel Non-invasive Biomarker for the Diagnosis of Non Alcoholic Fatty Liver (NAFL) and SteatoHepatitis (NASH) in a Population With High Risk of Metabolic Syndrome"

Who this might be right for
ObesityNASH - Nonalcoholic Steatohepatitis
University Hospital, Lille 158
Testing effectiveness (Phase 2)Looking for participantsNCT06588699
What this trial is testing

Digoxin In NASH (CODIN)

Who this might be right for
NASHNAFLDMASH - Metabolic Dysfunction-Associated Steatohepatitis+5 more
Yale University 144
Large-scale testing (Phase 3)Study completedNCT01754714
What this trial is testing

Study to Investigate the Effects of Different Doses of S-adenosyl-L-methionine (SAMe) in Subjects With Nonalcoholic Fatty Liver Disease and Non-treated Matched Healthy Volunteers as Control Group

Who this might be right for
Non Alcoholic Fatty Liver Disease
Abbott 108
Testing effectiveness (Phase 2)Study completedNCT00063232
What this trial is testing

Treating Nonalcoholic Steatohepatitis (NASH) With Metformin

Who this might be right for
Hepatitis
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) 28
Testing effectiveness (Phase 2)Study completedNCT01068444
What this trial is testing

The Efficacy and Safety of Pioglitazone in Patients With Nonalcoholic Steatohepatitis

Who this might be right for
Hepatitis
Kaohsiung Medical University Chung-Ho Memorial Hospital 90
Very early researchLooking for participantsNCT07185932
What this trial is testing

Efficacy and Safety of Rifaximin in Treating MAFLD

Who this might be right for
Metabolic-associated Fatty Liver Disease
Shanghai Changzheng Hospital 40
Not applicableStudy completedNCT04435054
What this trial is testing

Screening for NAFLD-related Advanced Fibrosis in High Risk Population in Diabetology.

Who this might be right for
Non-Alcoholic Fatty Liver Disease
Hospices Civils de Lyon 1,000
Not applicableStudy completedNCT07825467
What this trial is testing

Brown Adipose Tissue Activity and NAFLD Progression

Who this might be right for
Nonalcoholic Fatty Liver Disease
Renmin Hospital of Wuhan University 96
Testing effectiveness (Phase 2)Active Not RecruitingNCT05692492
What this trial is testing

A Randomized, Double-blind, Placebo-controlled Study of ZSP1601 in Adult Subjects With Nonalcoholic Steatohepatitis (NASH)

Who this might be right for
Nonalcoholic Steatohepatitis (NASH)
Guangdong Raynovent Biotech Co., Ltd 180
Not applicableStudy completedNCT04369807
What this trial is testing

Mapping Organ Health Following COVID-19 Disease Due to SARS-CoV-2 Infection

Who this might be right for
COVID-19
Perspectum 693
Not applicableLooking for participantsNCT05255978
What this trial is testing

A Prospective/Retrospective, Observational Follow-up Study of Chronic Hepatitis B With Non-alcoholic Fatty Liver Disease.

Who this might be right for
the Effect of NAFLD on CHB
Qin Ning 10,000
Not applicableUnknownNCT05108415
What this trial is testing

Development and Validation of a Multi-target, Blood-based NAFLD Diagnosis Test

Who this might be right for
NAFLDNASH - Nonalcoholic Steatohepatitis
HBI Solutions Inc. 1,500
Large-scale testing (Phase 3)WithdrawnNCT01384578
What this trial is testing

Pentoxiphylline and Vitamin E Versus Vitamin E in Patients With Non- Alcoholic Steatohepatitis

Who this might be right for
Non Alcoholic Steatohepatitis
Institute of Liver and Biliary Sciences, India
Next Page